Ke He
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- RNA modifications and cancer 7
- Histone Deacetylase Inhibitors Research 3
- Epigenetics and DNA Methylation 3
- Oncology 14
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Guoan Xiang (17 shared papers)Xiao‐Ming Mao (2 shared papers)Qianshan Ding (6 shared papers)Xiaopeng Duan (8 shared papers)D.J. Qiu (1 shared paper)Zhenglin Xia (8 shared papers)Rui Huang (6 shared papers)Hanning Wang (5 shared papers)
- Journals
- Journal of Crystal Growth (2 papers)Cell Death and Disease (2 papers)Biomedicines (2 papers)BioMed Research International (2 papers)Neurochemical Research (1 paper)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Ke He
54 papers receiving 890 citations
Peers
Comparison fields: 5 of 108
- Cancer Research 203
- Hepatology 57
- Molecular Biology 403
- Oncology 134
- Immunology 90
Countries citing papers authored by Ke He
This map shows the geographic impact of Ke He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke He more than expected).
Fields of papers citing papers by Ke He
This network shows the impact of papers produced by Ke He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke He. The network helps show where Ke He may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 77 | |
| 2 | 2015 | 59 | |
| 3 | 2014 | 52 | |
| 4 | 2014 | 51 | |
| 5 | 2016 | 51 | |
| 6 | 2018 | 48 | |
| 7 | 2020 | 44 | |
| 8 | 2017 | 42 | |
| 9 | 2016 | 32 | |
| 10 | 2018 | 29 | |
| 11 | 2024 | 29 | |
| 12 | 2019 | 28 | |
| 13 | 2013 | 27 | |
| 14 | 2020 | 24 | |
| 15 | 2014 | 23 | |
| 16 | 2010 | 22 | |
| 17 | LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p. | 2019 | 22 |
| 18 | 2011 | 18 | |
| 19 | 2015 | 17 | |
| 20 | 2016 | 14 |
About Ke He
Ke He is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Complementary and alternative medicine, having authored 64 papers that have together received 903 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (4 papers), Acupuncture Treatment Research Studies (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Autophagy in Disease and Therapy (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (203 citations), Hepatology (57 citations), Molecular Biology (403 citations), Oncology (134 citations) and Immunology (90 citations). Ke He has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Guoan Xiang, Xiao‐Ming Mao, Qianshan Ding, Xiaopeng Duan, D.J. Qiu, Zhenglin Xia, Rui Huang, Hanning Wang, Jinfeng Xiao and Honggang Yu. Their work appears in journals such as Journal of Crystal Growth, Cell Death and Disease, Biomedicines, BioMed Research International and Neurochemical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.